Global Stock News

Valuation without a playbook: assessing quantum in crypto, pharma and AI

Valuation without a playbook: assessing quantum in crypto, pharma and AI

Valuation without a playbook: assessing quantum in crypto, pharma and AI


Monique Sasson, Dame Elizabeth Gloster and Jennifer Haywood on the GAR Live Damages panel

A panel at GAR Live Damages discussed the challenges of determining quantum in fast-moving industries such as cryptocurrency, life sciences and artificial intelligence.  

Source link

Share this article

Scroll to Top